Century Therapeutics (IPSC) Asset Writedowns and Impairment (2023 - 2025)
Century Therapeutics (IPSC) posted quarterly Asset Writedowns and Impairment of $6.8 million for Q3 2025, up 56.3% quarter-over-quarter from $4.3 million in Q4 2024.
Century Therapeutics (IPSC) Asset Writedowns and Impairment (2023 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has reported Asset Writedowns and Impairment for 3 consecutive years, with $6.8 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $6.8 million; the TTM figure through Sep 2025 stood at $11.1 million (down 8.69% YoY), while the FY2025 annual figure was $6.8 million, up 56.3% from the prior year.
- Asset Writedowns and Impairment advanced to $6.8 million in Q3 2025 per IPSC's latest filing, from $4.3 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $12.1 million in Q4 2023 and bottomed at $4.2 million in Q2 2023.
- Historically, Asset Writedowns and Impairment has averaged $6.9 million across 3 years, with a median of $5.5 million in 2024.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 64.37% in 2024 and fell as far as 64.37% in 2024.
- Century Therapeutics' Asset Writedowns and Impairment stood at $12.1 million in 2023, then plunged by 64.37% to $4.3 million in 2024, then surged by 56.3% to $6.8 million in 2025.
- Business Quant data shows IPSC's Asset Writedowns and Impairment at $6.8 million in Q3 2025, $4.3 million in Q4 2024, and $12.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.76 Mn |
| Sep 30, 2025 | 6.76 Mn |
| Dec 31, 2024 | 4.33 Mn |
| Dec 31, 2024 | 4.33 Mn |
| Dec 31, 2023 | 12.15 Mn |
| Dec 31, 2023 | 12.15 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Jun 30, 2023 | 4.22 Mn |